Single-cell analysis reveals that TCF7L2 facilitates the progression of ccRCC via tumor-associated macrophages

Fengran Guo1, Yilong Gao2, Pengfei Zhou3

  • 1Department of Urology, Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.

Cellular Signalling
|October 4, 2024
PubMed
Abstract

Insights

Tumor-associated macrophages (TAMs) drive clear cell renal cell carcinoma (ccRCC) progression. This study identifies TCF7L2 as a key factor promoting TAM recruitment and M2 polarization, thus enhancing ccRCC invasion and metastasis.

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • Tumor-associated macrophages (TAMs) are implicated in clear cell renal cell carcinoma (ccRCC) recurrence and progression.
  • The precise mechanisms underlying TAM involvement in ccRCC remain unclear.

Purpose of the Study:

  • To elucidate the role and regulatory mechanisms of TAMs in ccRCC progression.
  • To identify key molecular players involved in TAM heterogeneity and function within the ccRCC microenvironment.

Main Methods:

  • Single-cell and transcriptome analysis to characterize TAM heterogeneity.
  • SCENIC for inferring regulatory networks.
  • CellChat for analyzing cell-cell interactions.
  • Pseudotime analysis for cell dynamics.
  • In vitro experiments to validate findings.

Main Results:

  • Identified a specific TAM subset, "TAM2," associated with ccRCC occurrence and metastasis.
  • TCF7L2 identified as a crucial transcription factor regulating TAM2 differentiation and heterogeneity.
  • TAM2 exhibits significant interactions with cancer and endothelial cells.
  • TCF7L2 overexpression in macrophages promotes ccRCC invasion and proliferation in vitro.

Conclusions:

  • TCF7L2 plays a pivotal role in ccRCC progression.
  • TCF7L2 enhances ccRCC by promoting TAM recruitment and M2-type polarization.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...